Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis

Journal of Neurology

Volumn 254, Issue 5, 2007, Pages 575-580

  Siciliano, G ^a   Piazza, S ^a   Carlesi, C ^a   Del Corona, A ^a   Franzini, M ^a   Pompella, A ^a   Malvaldi, G ^a   Mancuso, M ^a   Paolicchi, A ^a   Murri, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; IRON; NITRATE; NITRITE; PROTEIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PATHOGENESIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN METABOLISM; REDUCTION;

AGED; ALDEHYDES; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANTIOXIDANTS; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; IRON-SULFUR PROTEINS; MALE; MIDDLE AGED; NITRATES; NITRITES; OXIDATION-REDUCTION;

EID: 34249026030     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0301-1     Document Type: Article

References (36)

1. Abe T, Tohgi H, Isobe C, Murata T, Sato C (2002) Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res 70:447-450
2. Abe T, Isobe C, Murata T, Sato C, Tohgi H (2003) Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease. Neurosci Lett 336:105-108
3. Agar J, Durham H (2003) Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 4:232-242
4. Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, Pioro E, Harati Y, Brower RD, Levine JS, Heinicke HU, Seltzer W, Boss M, Brown RH Jr (2003) Sixteen mutations in the Cu/Zn superoxide dismutase gene in Amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 4:62-73
5. Appel V, Stewart SS, Smith G, Appel SH (1987) A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 22:328-333
6. Bär PR (2000) Motor neuron disease in vitro: the use of cultured motor neurons to study amyotrophic lateral sclerosis. Eur J Pharmacol 405:285-295
7. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364:584
8. Belsh JM (2000) ALS diagnostic criteria of El Escorial revisited: do they meet the needs of clinicians as well as researchers? Amyotroph Lateral Scler Other Motor Neuron Disord 1:57-60
9. Benzie IF, Strain JJ (1996) The Ferric Reducing Ability of Plasma (FRAP) as a measure of "Antioxidant Power": the FRAP assay. Anal Biochem 239:70-76.ù
10. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM (1999) Mitochondrial enzyme activity in amyotrophic lateral sclerosis, implications for the role of mitochondria in neuronal cell death. Ann Neurol 46:787-790
11. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128
12. Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, Lau SS, Mitchell JD, Lynch PG (1996) Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19:797-798
13. Gutteridge JM (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41:1819-1828
14. Halliwell B, Gutteridge JM (1995) The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 18:125-126
15. Heinecke JW, Li W, Daehnke HD, Goldstein JA (1993) Dityrosine, a specific marker of oxidation, in synthesized by the myeloperoxidasehydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 268:4069-4077
16. Huang LE, Willmore WG, Gu J, Goldberg MA, Bunn HF (1999) Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem 26:9038-44
17. MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA (1996) Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allograft. Proc Natl Acad Sci USA 93:11853-11858
18. Mancuso M, Conforti FL, Rocchi A, Tessitore A, Muglia M, Tedeschi G, Panza D, Monsurro M, Sola P, Mandrioli J, Choub A, DelCorona A, Manca ML, Mazzei R, Sprovieri T, Filosto M, Salviati A, Valentino P, Bono F, Caracciolo M, Simone IL, La Bella V, Majorana G, Siciliano G, Murri L, Quattrone A (2004) Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett 371:158-162
19. Orrell RW (2000) Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD-1) gene mutations. Neuromuscul Disord 10:63-68
20. Packer MA, Murphy MP (1994) Peroxynitrite cause calcium efflux from mitochondria which is prevented by cyclosporine A. FEBS Lett 345:237-240
21. Packer MA, Scarlett JL, Martin SW, Murphy MP (1997) Induction of the mitochondrial permeability transition by peroxynitrite. Biochem Soc Trans 25:909-914
22. Pfeiffer S, Gorren AC, Schmidt K, Werner ER, Hansert B, Bohle DS, Mayer B (1997) Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pHdependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J Biol Chem 272:3465-3470
23. Pompella A, Cambiaggi C, Dominici S, Paolicchi A, Tongiani R, Comporti M (1996) Single-cell investigation by laser scanning confocal microscopy of cytochemical alterations resulting from extracellular oxidant challenge. Histochem Cell Biol 105:173-178
24. Radi R, Rodriguez M, Castro L, Telleri R (1994) Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308:89-95
25. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, Chakrabartty A (2004) Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279:15499-15504
26. Shaw PJ, Ince PG, Falkous G, Mantle D (1995) Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 38:691-695
27. Shukla R, Rajani M, Barthwal MK, Srivastava N, Dikshit M (2003) Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease. Int J Neurosci 113:1043-1054
28. Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH (2004) Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62:1758-1765
29. Smith RG, Henry YK, Mattson MP, Appel SH (1998) Presence of 4-Hydroxynonenal in Cerebrospinal Fluid of Patients with Sporadic Amyotrophic Lateral Sclerosis. Ann Neurol 44:696-699
30. Vielhaber S, Kunz D, Winkler K, Wiedemann FR, Kirches E, Feistner H, Heinze HJ, Elger CE, Schubert W, Kunz WS (2000) Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123:1339-1348
31. Wakai M, Mokuno K, Hashizume Y, Kato K (1994) An immunohistochemical study of the neuronal expression of manganese superoxide dismutase in sporadic amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 88:151-158
32. White RJ, Reinolds IJ (1996) Mitochondrial depolarization in glutamatestimulated neurons: an early signal specific to excitotoxin exposure. J Neurosci 16:5688-5697
33. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156:65-72
34. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313
35. Zarkovic K (2003) 4-Hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24:293-303
36. Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689